Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Both microneedling and injections are equally effective for treating alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Tofacitinib significantly improved skin and hair conditions without side effects.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Biosimilars lower costs but don't significantly improve access.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.